As of January 2025 Relmada Therapeutics has a market cap of €10.82 Million. This makes Relmada Therapeutics the world's 10070th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 21st, 2025 the market cap of Relmada Therapeutics was reported to be: